Home
About Us
Company Overview
Executive Leadership Team
Board of Directors
Careers
Physicians &
Nurses
Pure-Vu EVS System
User Testimonials
Clinical Evidence
Investigator-Initiated Study
Helpful Hints
Inpatient Upper GI Endoscopy (EGD)
Inpatient Colonoscopy
Outpatient Colonoscopy
Frequently Asked Questions
Facility
Administrators
Overview
User Testimonials
Clinical Evidence
News &
Media
Customer Notices
Customer Notices
Content Library
Investors
Overview
News & Events
Company Information
Financial Results
Stock Data
SEC Filings
Governance
Help
Search
Search
All SEC Filings
Investor Tools
Email Alerts
Contacts
RSS News Feed
SEC Filings
Quick Links
Overview
All
SEC Filings
Annual &
Quarterly Reports
Section
16 Filings
Filing Type:
View All
10-K
10-Q
25-NSE
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
Date
Form
Description
PDF
XBRL
Pages
01/05/18
S-1
General form of registration statement for all companies including face-amount certificate companies
Documents
EX-2.1
EX-3.1
EX-3.2
EX-3.3
EX-3.4
EX-3.5
EX-4.1
EX-4.2
EX-4.3
EX-4.4
EX-4.5
EX-4.6
EX-4.7
EX-4.8
EX-4.9
EX-10.1
EX-10.2
EX-10.3
EX-10.4
EX-10.5
EX-10.6
EX-10.7
EX-10.8
EX-10.9
EX-10.10
EX-10.11
EX-10.12
EX-10.13
EX-10.14
EX-10.15
EX-10.16
EX-10.17
EX-10.18
EX-21.1
EX-23.1
913
11/02/17
UPLOAD
SEC-generated letter
2
10/06/17
DRSLTR
Correspondence Related to Draft Registration Statement
7
10/06/17
DRS
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Documents
EX-2.1
EX-3.1
EX-3.2
EX-3.3
EX-3.4
EX-4.1
EX-4.2
EX-4.3
EX-4.4
EX-4.5
EX-4.6
EX-4.7
EX-10.1
EX-10.2
EX-10.3
EX-10.4
EX-10.5
EX-10.6
EX-10.7
EX-10.8
EX-10.9
EX-10.10
EX-10.11
EX-10.12
EX-10.13
EX-10.14
EX-10.15
EX-10.16
EX-10.17
EX-10.18
EX-21.1
871
10/06/17
DRS/A
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Documents
EX-10.18
170
07/18/17
UPLOAD
SEC-generated letter
3
07/03/17
DRSLTR
Correspondence Related to Draft Registration Statement
13
07/03/17
DRS/A
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Documents
EX-4.6
EX-4.7
EX-10.13
205
05/09/17
UPLOAD
SEC-generated letter
6
04/12/17
DRS
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Documents
EX-2.1
EX-3.1
EX-3.2
EX-3.3
EX-3.4
EX-4.1
EX-4.2
EX-4.3
EX-4.4
EX-4.5
EX-10.1
EX-10.2
EX-10.3
EX-10.4
EX-10.5
EX-10.6
EX-10.7
EX-10.8
EX-10.9
EX-10.10
EX-10.11
EX-10.12
EX-10.13
EX-10.14
EX-10.15
EX-10.16
EX-10.17
EX-21.1
796
Previous
1…
30
31
32
33
34
35
36
37
38
39
Next
SIGN-UP FOR EMAIL ALERTS
We're sorry
, but this form has spam protection that requires JavaScript to be enabled to work correctly. If you'd like to contact us via this form, please
enable scripts in your browser
and reload the page.
First Name
Last Name
Email Address
Phone
Country
Contact Type:
Individual Investor
Analyst
Broker/Investment Advisor
Portfolio Manager
Banker/Financing Source
Press/Media
Consultant
Employee
Customer/Client
Student
Other
All Press Releases
All SEC Filings
10-K & 10-Q Reports
Current Reports
Insider Transactions
Proxy Information
Comments
Submit
